134 related articles for article (PubMed ID: 38063052)
1. Single-cell RNA sequencing reveals diverse B cell phenotypes in patients with anti-NMDAR encephalitis.
Li S; Hu X; Wang M; Yu L; Zhang Q; Xiao J; Hong Z; Zhou D; Li J
Psychiatry Clin Neurosci; 2024 Mar; 78(3):197-208. PubMed ID: 38063052
[TBL] [Abstract][Full Text] [Related]
2. Antibody-secreting cells as a source of NR1-IgGs in N-methyl-D-aspartate receptor-antibody encephalitis.
Qing Li A; Jie Li X; Liu X; Gong X; Ru Ma Y; Cheng P; Jiao Wang X; Mei Li J; Zhou D; Hong Z
Brain Behav Immun; 2024 May; 120():181-186. PubMed ID: 38825049
[TBL] [Abstract][Full Text] [Related]
3. Blood and CSF findings of cellular immunity in anti-NMDAR encephalitis.
Wang J; Luo L; Meng Z; Ren Y; Tang M; Huang Z; Yang B; Niu Q; Zhou D; Wang M; Li J
Int Immunopharmacol; 2024 Mar; 130():111743. PubMed ID: 38430802
[TBL] [Abstract][Full Text] [Related]
4. Contribution of cerebrospinal fluid antibody titers and sex to acute cerebral blood flow in patients with anti-NMDAR autoimmune encephalitis.
Miao A; Wang K
Front Immunol; 2024; 15():1299898. PubMed ID: 38495877
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's Lymphoma of the Central Nervous System with N-Methyl-D-Aspartate Receptor Antibody Positivity - A Case Report.
Tunc H; Camkiran E; Gemici A; Irmak S; Ismayilzade H; Aliyev R; Bozkurt S; Midi I
Acta Neurol Taiwan; 2024 Jun; 33(2)():86-92. PubMed ID: 37848241
[TBL] [Abstract][Full Text] [Related]
6. Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
Al-Diwani A; Theorell J; Damato V; Bull J; McGlashan N; Green E; Kienzler AK; Harrison R; Hassanali T; Campo L; Browne M; Easton A; Soleymani Majd H; Tenaka K; Iorio R; Dale RC; Harrison P; Geddes J; Quested D; Sharp D; Lee ST; Nauen DW; Makuch M; Lennox B; Fowler D; Sheerin F; Waters P; Leite MI; Handel AE; Irani SR
Brain; 2022 Aug; 145(8):2742-2754. PubMed ID: 35680425
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells.
Castleman MJ; Stumpf MM; Therrien NR; Smith MJ; Lesteberg KE; Palmer BE; Maloney JP; Janssen WJ; Mould KJ; Beckham JD; Pelanda R; Torres RM
Front Immunol; 2022; 13():988125. PubMed ID: 36131937
[TBL] [Abstract][Full Text] [Related]
8. N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications.
Makuch M; Wilson R; Al-Diwani A; Varley J; Kienzler AK; Taylor J; Berretta A; Fowler D; Lennox B; Leite MI; Waters P; Irani SR
Ann Neurol; 2018 Mar; 83(3):553-561. PubMed ID: 29406578
[TBL] [Abstract][Full Text] [Related]
9. VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor Encephalitis.
Monson N; Smith C; Greenberg H; Plumb P; Guzman A; Tse K; Chen D; Zhang W; Morgan M; Speed H; Powell C; Batra S; Cowell L; Christley S; Vernino S; Blackburn K; Greenberg B
J Immunol; 2023 Nov; 211(9):1332-1339. PubMed ID: 37712756
[TBL] [Abstract][Full Text] [Related]
10. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the relation between cerebrospinal fluid antibody titers and clinical characteristics in pediatric patients with anti-N-methyl-D-aspartate receptor encephalitis.
Yang H; Ren H; Zhao J; Yu T; Cai Q; Luo R
Eur J Paediatr Neurol; 2023 Nov; 47():88-93. PubMed ID: 37826915
[TBL] [Abstract][Full Text] [Related]
12. Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.
Kreye J; Wenke NK; Chayka M; Leubner J; Murugan R; Maier N; Jurek B; Ly LT; Brandl D; Rost BR; Stumpf A; Schulz P; Radbruch H; Hauser AE; Pache F; Meisel A; Harms L; Paul F; Dirnagl U; Garner C; Schmitz D; Wardemann H; Prüss H
Brain; 2016 Oct; 139(Pt 10):2641-2652. PubMed ID: 27543972
[TBL] [Abstract][Full Text] [Related]
13. The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms.
Hinotsu K; Miyaji C; Yada Y; Kawai H; Sakamoto S; Okahisa Y; Tsutsui K; Kanbayashi T; Tanaka K; Takao S; Kishi Y; Takaki M; Yamada N
Schizophr Res; 2022 Oct; 248():292-299. PubMed ID: 36130472
[TBL] [Abstract][Full Text] [Related]
14. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
Front Immunol; 2021; 12():686483. PubMed ID: 34276673
[TBL] [Abstract][Full Text] [Related]
15. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
16. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation.
Li Y; Yang K; Zhang F; Wang J; Shen H; Liu M; Guo J; Wang J
Front Immunol; 2022; 13():971659. PubMed ID: 36389787
[TBL] [Abstract][Full Text] [Related]
17. Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease.
Xu M; Jiang Y; Wang J; Liu J; Liu C; Liu D; Yang S
BMC Immunol; 2019 Jun; 20(1):16. PubMed ID: 31159728
[TBL] [Abstract][Full Text] [Related]
18. Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics.
Ly LT; Kreye J; Jurek B; Leubner J; Scheibe F; Lemcke J; Wenke NK; Reincke SM; Prüss H
J Neurol; 2018 Nov; 265(11):2625-2632. PubMed ID: 30187160
[TBL] [Abstract][Full Text] [Related]
19. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay.
Suh-Lailam BB; Haven TR; Copple SS; Knapp D; Jaskowski TD; Tebo AE
Clin Chim Acta; 2013 Jun; 421():1-6. PubMed ID: 23454475
[TBL] [Abstract][Full Text] [Related]
20. The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis.
Hümmert MW; Jendretzky KF; Fricke K; Gingele M; Ratuszny D; Möhn N; Trebst C; Skripuletz T; Gingele S; Sühs KW
Sci Rep; 2023 Aug; 13(1):12696. PubMed ID: 37542085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
